Publicaciones en las que colabora con Fernando Baquero Artigao (46)

2024

  1. QuantiFERON-TB reversion in children and adolescents with tuberculosis

    Frontiers in Immunology, Vol. 15

  2. Renal Function Impairment in Children With Congenital Cytomegalovirus Infection: A Cross-sectional Study

    The Pediatric infectious disease journal, Vol. 43, Núm. 3, pp. 257-262

  3. Results of the REIV-TOXO national survey on prenatal screening for toxoplasmosis in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 9, pp. 478-483

  4. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

    The Journal of infectious diseases, Vol. 229, Núm. 1, pp. 95-107

  5. T-Cell Immune Responses in Newborns and Long-Term Sequelae in Congenital Cytomegalovirus Infection (CYTRIC Study)

    Journal of Pediatrics, Vol. 272

2023

  1. Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age

    Antibiotics, Vol. 12, Núm. 2

  2. Epidemiology and clinical features of Streptococcus pyogenes bloodstream infections in children in Madrid, Spain

    European Journal of Pediatrics, Vol. 182, Núm. 7, pp. 3057-3062

  3. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age

    The Journal of infectious diseases, Vol. 227, Núm. 11, pp. 1293-1302

  4. The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmission

    PLoS ONE, Vol. 18, Núm. 2 February

2022

  1. Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study

    Thorax, Vol. 77, Núm. 10, pp. 1023-1029

  2. Impact of the COVID-19 Pandemic on the Diagnosis of Congenital Cytomegalovirus Infection in Spain

    Pediatric Infectious Disease Journal, Vol. 41, Núm. 7, pp. 590-592

  3. Staphylococcus aureus Community-acquired Pneumonia in Children After 13-Valent Pneumococcal Vaccination (2008-2018): Epidemiology, Clinical Characteristics and Outcomes

    The Pediatric infectious disease journal, Vol. 41, Núm. 5, pp. e235-e242

2021

  1. Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children

    Journal of Pediatrics, Vol. 236, pp. 211-218.e2

2020

  1. Carbapenem-resistant Gram-negative bacterial infections in children

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 3

  2. Growth Patterns in Children with Congenital Cytomegalovirus Infection

    Pediatric Infectious Disease Journal, pp. 1230-1235

  3. Recommendations on the clinical management of the COVID-19 infection by the «new coronavirus» SARS-CoV2. Spanish Paediatric Association working group

    Anales de Pediatria, Vol. 92, Núm. 4, pp. 241.e1-241.e11

2019

  1. Documento de posicionamiento de la Asociación Española de Pediatría-Sociedad Española de Infectología Pediátrica (AEP-SEIP) sobre el tratamiento de las infecciones por bacterias multirresistentes

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 91, Núm. 5, pp. 351-351

  2. Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study

    Vaccine, Vol. 37, Núm. 16, pp. 2200-2207

  3. Is Polymerase Chain Reaction in Neonatal Dried Blood Spots Reliable for the Diagnosis of Congenital Cytomegalovirus Infection?

    The Pediatric infectious disease journal, Vol. 38, Núm. 5, pp. 520-524

  4. Linezolid-containing Treatment Regimens for Tuberculosis in Children

    Pediatric Infectious Disease Journal, Vol. 38, Núm. 3, pp. 263-267